Search research articles
Contact Us
Filters
Showing results (81-90 of 148) with videos related to
Page
of 15
Sort By:
Obstetrics and Gynecology
|
August 1, 1995
Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer
F Nagele, E Petru, M Medl, et al.
International Journal of Cancer
|
November 11, 1992
Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 pre-menopausal women
M F Gnant, M Seifert, R Jakesz, et al.
Anticancer Research
|
February 19, 2002
Does long-term application of granulocyte colony-stimulating factor adversely influence overall survival in patients with ovarian cancer? A clinical study
C Peters-Engl, M Medl, U Denison, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1993
[High-dose epirubicin in combination with high-dose ifosfamide plus granulocyte colony stimulating factor in patients with advanced platin-pretreated ovarian cancer. Phase I-II study]
E Küffer, B Fazeny, P Speiser, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 1, 1992
Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancer
P. Sevelda, N. Vavra, R. Fitz, et al.
Geburtshilfe Und Frauenheilkunde
|
March 1, 1992
[Prognostic factors of radically operated stage Ib cervix cancer]
N Vavra, H Kucera, W Eppel, et al.
Geburtshilfe Und Frauenheilkunde
|
May 1, 1994
[The value of the "vascular invasion" factor for prognosis of breast cancer]
C Kurz, A Obermair, F Nagele, et al.
Gynecologic Oncology
|
June 1, 1997
Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study
Ch Kurz, Ch Marth, G Windbichler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1991
Clonogenic growth in vitro: an independent biologic prognostic factor in ovarian carcinoma
C Dittrich, E Dittrich, P Sevelda, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
April 1, 1993
Prognostic factors related to recurrent endometrial carcinoma following initial surgery
N Vavra, U Denison, H Kucera, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 148) with videos related to
Sort By:
Page
of 15
Obstetrics and Gynecology
|
August 1, 1995
Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer
F Nagele, E Petru, M Medl, et al.
International Journal of Cancer
|
November 11, 1992
Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 pre-menopausal women
M F Gnant, M Seifert, R Jakesz, et al.
Anticancer Research
|
February 19, 2002
Does long-term application of granulocyte colony-stimulating factor adversely influence overall survival in patients with ovarian cancer? A clinical study
C Peters-Engl, M Medl, U Denison, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1993
[High-dose epirubicin in combination with high-dose ifosfamide plus granulocyte colony stimulating factor in patients with advanced platin-pretreated ovarian cancer. Phase I-II study]
E Küffer, B Fazeny, P Speiser, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 1, 1992
Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancer
P. Sevelda, N. Vavra, R. Fitz, et al.
Geburtshilfe Und Frauenheilkunde
|
March 1, 1992
[Prognostic factors of radically operated stage Ib cervix cancer]
N Vavra, H Kucera, W Eppel, et al.
Geburtshilfe Und Frauenheilkunde
|
May 1, 1994
[The value of the "vascular invasion" factor for prognosis of breast cancer]
C Kurz, A Obermair, F Nagele, et al.
Gynecologic Oncology
|
June 1, 1997
Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study
Ch Kurz, Ch Marth, G Windbichler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1991
Clonogenic growth in vitro: an independent biologic prognostic factor in ovarian carcinoma
C Dittrich, E Dittrich, P Sevelda, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
April 1, 1993
Prognostic factors related to recurrent endometrial carcinoma following initial surgery
N Vavra, U Denison, H Kucera, et al.
Page
of 15